Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study

MLA

John WC Chang, et al. “Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutations: A Prospective Study.” Biomedical Journal, vol. 38, no. 3, June 2015, pp. 221–28. EBSCOhost, https://doi.org/10.4103/2319-4170.138320.

APA

John WC Chang, Ming-Mo Hou, Jia-Juan Hsieh, Yun-Chung Cheung, Hung-Ming Wang, Jen-Shi Chen, Cheng-Hsu Wang, Chih-Hung Chen, Kun-Yun Yeh, Li-Ying Ou, Chia-Hsun Hsieh, Hong-Dar Isaac Wu, Ying-Tsong Chen, Il-Chi Chang, & Shiu-Feng Huang. (2015). Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study. Biomedical Journal, 38(3), 221–228. https://doi.org/10.4103/2319-4170.138320

Chicago

John WC Chang, Ming-Mo Hou, Jia-Juan Hsieh, Yun-Chung Cheung, Hung-Ming Wang, Jen-Shi Chen, Cheng-Hsu Wang, et al. 2015. “Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutations: A Prospective Study.” Biomedical Journal 38 (3): 221–28. doi:10.4103/2319-4170.138320.